Johnson Johnson Aktie
138,30
EUR
-1,14
EUR
-0,82
%
143,44
USD
-0,12
USD
-0,08
%
nachbörslich
Es gab keine Analysen zu dieser Aktie in den letzten sechs Monaten.
Kursziele der Johnson Johnson-Aktie in
Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Alexion Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| Allergan Inc. | 0 | 0 | 0 | - | - |
| APONTIS PHARMA | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 5 | 4 | 0 | 138,26 GBP | - |
| Bayer | 1 | 9 | 0 | 27,22 EUR | +43,44% |
| Beiersdorf AG | 6 | 4 | 1 | 144,00 EUR | +17,07% |
| BioNTech (ADRs) | 4 | 2 | 0 | 136,50 USD | +22,60% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| Celgene Corp. | 0 | 0 | 0 | - | - |
| CureVac | 0 | 1 | 0 | - | - |
| Douglas | 4 | 0 | 0 | 30,50 EUR | +58,85% |
| Fresenius Medical Care (FMC) St. | 2 | 5 | 4 | 40,03 EUR | -8,96% |
| Fresenius SE & Co. KGaA (St.) | 8 | 2 | 0 | 39,50 EUR | +17,88% |
| GSK PLC Registered Shs | 2 | 6 | 1 | 17,14 GBP | +29,65% |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 7 | 1 | 0 | 186,71 EUR | - |
| Moderna Inc | 0 | 2 | 1 | 67,33 USD | +70,20% |
| MorphoSys | 1 | 3 | 0 | 35,38 EUR | - |
| Nestlé SA (Nestle) | 4 | 7 | 0 | 89,50 CHF | +20,62% |
| Novartis AG | 3 | 5 | 1 | 98,86 CHF | +13,58% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 3 | 3 | 0 | 31,20 USD | +21,07% |
| Procter & Gamble Co. | 0 | 0 | 0 | - | - |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 5 | 2 | 1 | 109,86 EUR | - |
| Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
| STADA | 0 | 0 | 0 | - | - |
| Unilever plc | 4 | 4 | 2 | 47,93 GBP | - |
| Valneva | 0 | 0 | 0 | - | - |